NEW YORK (GenomeWeb) – Exact Sciences announced before the opening of the market on Friday that it is offering $190 million in aggregate principal amount of its 1.0 percent convertible senior notes due 2025. The firm said it expects the offering to provide gross proceeds of $202.4 million.

Exact upsized the offering Friday after originally announcing a $150 million offering after the close of the market on Thursday. The initial public offering price for the Notes will be 106.5 percent of face value plus accrued interest from Jan. 17.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.